Action 18
Take all possible measures to rapidly complete development of priority paediatric drugs and formulations in the pipeline, with the goal of providing the maximum number of new formulations by end of 2018, especially for infants and young children.
Committed by:
Pharmaceutical companies
Sub-Actions & Milestones
Sub-action 18.1

Take all possible measures to rapidly complete development of priority paediatric drugs and formulations in the pipeline

Pharmceutical Companies

ViiV will be requesting a meeting with FDA early this summer to review development plans.

-

Milestone 18.1.1

-

-

-

-

Document (s)

-

-

-

-

Updates

Notes

Responsible